Russo challenges Donalds and Jolly to debate Florida's insurance crisis and calls for return of elected insurance commissioner. Florida insurance crisis debate raises possibility of regulatory shifts affecting Allstate's state operations.
| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | 2 | 7 | 2 | 3 | 3 | 2 | — | 2 | 1 | — | 2 | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 4.34 |
—
—
—
|
| 2025 | 4.00 |
—
—
—
—
|
| 2024 | 3.68 |
—
—
—
—
|
| 2023 | 3.56 |
—
—
—
—
|
| 2022 | 3.40 |
—
—
—
—
|
| 2021 | 3.24 |
—
—
—
—
|
| 2020 | 2.16 |
—
—
—
—
|
| 2019 | 2.00 |
—
—
—
—
|
| 2018 | 1.84 |
—
—
—
—
|
| 2017 | 1.48 |
—
—
—
—
|
| 2016 | 1.32 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 722.00 | 704.00 | 678.00 | 840.00 |
| Receivables | 18,853.00 | 19,538.00 | 19,975.00 | 19,744.00 |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 19,575.00 | 20,242.00 | 20,653.00 | 20,584.00 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 67,267.00 | 70,393.00 | 71,578.00 | 71,919.00 |
| ST’ Debt | — | — | — | — |
| Other | 888.00 | — | — | — |
| 68,155.00 | 70,393.00 | 71,578.00 | 71,919.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 16,941.00 | 18,596.00 | — | — |
—
|
| ’25 | 16,452.00 | 16,633.00 | 17,255.00 | 17,345.00 |
67,685.00
|
| ’24 | 15,259.00 | 15,714.00 | 16,627.00 | 16,506.00 |
64,106.00
|
| ’23 | 13,786.00 | 13,979.00 | 14,497.00 | 14,832.00 |
57,094.00
|
| ’22 | 12,336.00 | 12,219.00 | 13,208.00 | 13,648.00 |
51,411.00
|
| ’21 | 12,451.00 | 12,646.00 | 12,480.00 | 13,024.00 |
50,601.00
|
| ’20 | 9,866.00 | 10,403.00 | 10,678.00 | 10,962.00 |
41,909.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 3,562.00 | 2,634.00 | — | — |
—
|
| ’25 | 1,964.00 | 1,873.00 | 3,284.00 | 2,989.00 |
10,110.00
|
| ’24 | 1,666.00 | 2,359.00 | 3,201.00 | 1,705.00 |
8,931.00
|
| ’23 | 601.00 | 1,169.00 | 1,233.00 | 1,225.00 |
4,228.00
|
| ’22 | 432.00 | 1,673.00 | 2,046.00 | 970.00 |
5,121.00
|
| ’21 | 1,388.00 | 1,528.00 | 1,329.00 | 871.00 |
5,116.00
|
| ’20 | 1,027.00 | 1,849.00 | 1,296.00 | 1,319.00 |
5,491.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 3,522.00 | 2,591.00 | — | — |
—
|
| ’25 | 1,872.00 | 1,874.00 | 3,236.00 | 2,900.00 |
9,882.00
|
| ’24 | 1,643.00 | 2,303.00 | 3,138.00 | 1,655.00 |
8,739.00
|
| ’23 | 522.00 | 1,126.00 | 1,178.00 | 1,162.00 |
3,988.00
|
| ’22 | 302.00 | 1,575.00 | 1,922.00 | 1,111.00 |
4,910.00
|
| ’21 | 1,327.00 | 1,392.00 | 1,240.00 | 812.00 |
4,771.00
|
| ’20 | 962.00 | 1,748.00 | 1,227.00 | 1,246.00 |
5,183.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 9.25 | 12.51 | — | — |
—
|
| ’25 | 2.11 | 7.76 | 13.95 | 14.37 |
38.06
|
| ’24 | 4.46 | 1.13 | 4.33 | 7.07 |
16.99
|
| ’23 | (1.31) | (5.29) | (0.16) | 5.52 |
(1.20)
|
| ’22 | 2.24 | (3.81) | (2.58) | (1.17) |
(5.22)
|
| ’21 | (4.60) | 5.26 | 1.71 | 2.73 |
4.96
|
| ’20 | 1.59 | 3.86 | 3.58 | 8.45 |
17.31
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 111.85 | 100.57 | 140.33 | 176.00 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 144.46 | 144.99 | 209.88 | 215.89 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 54,500 | 53,400 | 55,400 | 53,300 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.94 | 1.07 | 1.16 | 1.27 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 51,411.00 | 57,094.00 | 64,106.00 | 67,685.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 25.49% | 26.19% | 36.08% | 43.70% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1,830.00) | (348.00) | 5,761.00 | 13,156.00 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (3.56%) | (0.61%) | 8.99% | 19.44% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1,342.00) | (213.00) | 4,599.00 | 10,266.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 847.00 | 704.00 | 555.00 | 482.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 189.57 | 217.50 | 242.55 | 256.77 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | (5.22) | (1.20) | 17.22 | 38.56 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.88 | 16.11 | 33.79 | 38.35 | ‡‡‡‡ | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.78) | (0.91) | (0.73) | (0.86) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.10 | 15.19 | 33.06 | 37.49 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 64.02 | 67.16 | 80.84 | 116.04 | ‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 271.20 | 262.50 | 264.30 | 263.60 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.00 | 0.00 | 11.21 | 5.38 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.72 | 0.66 | 0.79 | 0.81 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.41 | 2.42 | 2.63 | 1.92 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.86 | 0.79 | 0.91 | 0.91 | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.02 | 11.28 | 6.68 | 6.24 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5,121.00 | 4,228.00 | 8,931.00 | 10,110.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (211.00) | (240.00) | (192.00) | (228.00) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,910.00 | 3,988.00 | 8,739.00 | 9,882.00 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (43,789.00) | (48,580.00) | (50,151.00) | (50,925.00) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7,964.00 | 7,942.00 | 8,085.00 | 7,490.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7,228.00 | 7,220.00 | 7,381.00 | 6,812.00 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17,363.00 | 17,630.00 | 21,367.00 | 30,589.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.41%) | (0.31%) | 4.23% | 8.79% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (3.67%) | 0.50% | 13.53% | 20.07% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (7.23%) | (2.04%) | 26.00% | 42.39% | — | — | — |
ROE
|
Allstate Corporation (ALL) has engineered impressive revenue growth, surging from $37.4 billion in 2016 to $64.1 billion in 2024 and projected to hit $75.4 billion by 2027 at an 8% CAGR, driven by premium hikes, acquisitions like SquareTrade, and operational efficiencies that boosted revenue per employee 35% and per share 142% via aggressive buybacks. Yet, the insurance sector’s volatility shines through in profitability swings: catastrophic losses from 2022 hurricanes and storms flipped billions in profits to deep red ink, but 2024 delivered a stunning $4.6 billion net income rebound with 26% ROE and 13.5% ROIC, fueled by premium growth outpacing claims and rising investment income.
The balance sheet remains a fortress, with shareholders’ equity up 49% long-term, steady net debt, and explosive FCF/share growth to $33 in 2024, supporting dividends amid puny capex. Valuations scream bargain—trailing P/E at 11, forward P/E dipping to 6.7 by 2025, PS 0.8, and EV/FCF 6.7—lagging the revenue trajectory and implying undervaluation, though recent insider selling (no buys, CEO dumping shares) warrants caution.
Analysts forecast 19% upside on average, with EPS climbing to $26+ by 2027 and EBT margins nearing 20%, banking on rate hikes, AI efficiencies, and moderate weather. Shares trade near recent lows despite the FCF boom, decoupling from fundamentals and positioning ALL as a compelling recovery play for patient investors eyeing 15-20% annual returns—if catastrophes and insider trends stabilize.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.